STAA News

Latest breaking news and updates for STAA stock.

Track all markets on TradingView

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STAA, YMAB, DNOW on Behalf of Shareholders

NEW YORK, Aug. 12, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breach...

How might the investigation influence analyst coverage, target price revisions, and consensus recommendations? What is the potential effect on STAAR Surgical's relationships with key customers, suppliers, and partners? How are the other companies under investigation (YMAB, DNOW) likely to influence market sentiment toward STAAR Surgical?
Lawsuits
15 days ago
Read more prnewswire

Shareholder Alert: The Ademi Firm Investigates Whether STAAR Surgical Company Is Obtaining a Fair Price for Its Public Shareholders

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating STAAR (NASDAQ: STAA) for possible breaches of fiduciary duty and other violations of law in its transaction with Alcon Inc. Click here to...

How will the news affect investor sentiment toward the broader ophthalmology sector and related peer companies? What are the possible outcomes of the investigation (e.g., price adjustment, deal renegotiation, or termination) and their respective probabilities? How might the investigation influence Alcon's strategic plans and their willingness to proceed with the transaction?
Mergers
20 days ago
Read more businesswire

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of STAAR Surgical Company (NASDAQ: STAA)

NEW YORK, Aug. 7, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is...

What risk mitigation measures (e.g., insurance, legal defenses) does STAAR have in place for this litigation? How might this lawsuit affect the company's strategic initiatives, such as product launches or M&A activity? What is the track record of Monteverde & Associates in similar biotechnology or medical device cases?
Lawsuits
20 days ago
Read more prnewswire

STAAR SURGICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of STAAR Surgical Company - STAA

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of ST...

What legal precedents exist for similar attorney‑general‑led investigations that have impacted M&A deals? How might the investigation affect the short‑term volatility and liquidity of STAA’s stock on the NasdaqGM? What is the probability of a competing bid emerging from other strategic or private‑equity players?
Mergers
20 days ago
Read more businesswire

STAAR Surgical Reports Second Quarter 2025 Results

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer¼ Lenses (EVO ICLℱ) for vision correction, t...

Will management provide any guidance on sales velocity of EVO ICL post‑inventory reduction? How does the current valuation metrics (PE, EV/EBITDA) look after this earnings release? What is the projected impact on net income and net profit margin for the full year?
Earnings
21 days ago
Read more businesswire

STAA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of STAAR Surgical Company Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of STAAR Surgical Company (NASDAQ: STAA) to Alcon for $28.00 per share in cash is fair to...

What are the tax implications for shareholders if the deal is re‑priced, renegotiated, or ultimately cancelled? What impact will a potential delay or cancellation have on STAAR’s liquidity and the ability of shareholders to trade the stock? How does this proposed sale compare to recent M&A transactions in the ophthalmic/medical device sector in terms of premium, structure, and shareholder approval rates?
Mergers
23 days ago
Read more businesswire